Gail Cohen | Vice President, Corporate Communications |
Rick Winningham | Chief Executive Officer |
Philip Worboys | Senior Vice President, Research and Translational Science |
Frank Pasqualone | Chief Commercial Operations Officer |
Andrew Hindman | Chief Financial Officer |
Brett Haumann | Senior Vice President, Clinical Development and Chief Medical Officer |
Brad Canino | SVB Leerink |
Tyler Van Buren | Piper Sandler |
Douglas Tsao | H.C. Wainwright |
Joseph Stringer | Needham and Company |
Ladies and gentlemen, good afternoon, I would like to welcome everyone to the Theravance Biopharma Conference Call.
During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the Company's formal remarks. [Operator Instructions] Today's conference call is being recorded.
And now I'd like to turn the call over to Gail Cohen, Vice President, Corporate Communications and Investor Relations.